Prostate cancer is the second most common cancer in American men.  While the disease is prevalent across the country, the screening guidelines are not.  Prostate cancer screenings have always been somewhat controversial because the tests often alert physicians to the presence of cancer, but there is no precise way to determine, definitively, whether the cancer […]

Learn More

Radiation therapy can be classified according to the types of radiation particles or waves that are used to deliver the treatment.  The three major types of radiation therapy are photons, electrons, or protons.  While all three types have similar effects on tumor tissue and damage cancer cells, photons and electrons are the most readily available, […]

Learn More

May is National Brain Tumor Awareness Month.  Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a […]

Learn More

Vernon Traxler suffered from painful trigeminal neuralgia for over 16 years before he found relief with CyberKnife. Watch Vernon explain what those years felt like and how he feels now after being treated by CyberKnife.

Learn More

Coping with Cancer Through the Holidays During the COVID-19 PandemicAs the classic holiday song goes, it is the most wonderful time of the year. But do you know what else the happiest season of all brings? Stress. This year is no exception, especially with the added threat of the COVID-19 pandemic. It is no secret that […]

Learn More

As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments.  Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]

Learn More

When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration.  While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them.  That choice is often based on treatment outcomes and side effects, and […]

Learn More

Learn More

Learn More

Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer.  The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]

Learn More